Navigation Links
NeoStem to Present at Two Investor Conferences Thursday, November 18, 2010
Date:11/18/2010

NEW YORK, Nov. 18, 2010 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced that Dr. Robin Smith, the Company's Chairman and CEO, will present at the 2010 Maxim Group Growth Conference this morning and at the Proactive Investors One2One Investor Forum this evening. Both events will be held in New York, NY.

The 2010 Maxim Group Growth Conference will be held in Carnegie/Alvin room at the Grand Hyatt Hotel in New York City, NY.  Dr. Smith is scheduled to make a presentation from 10-10:30 a.m. today, November 18, 2010 and will be available to meet with investors throughout the conference.  The Proactive Investors One2One Investor Forum will be held this evening in the Whitney Room at the Intercontinental New York Barclay Hotel in New York, NY.  Dr. Smith is scheduled to present 6:30 p.m. and will host a question and answer session after her formal presentation.

"I look forward to the opportunity to showcase NeoStem for investors, industry experts and those from the scientific community at both these events today," said Dr. Robin Smith.  "We are proud of the growth that NeoStem is experiencing at present and the future opportunities that are open to NeoStem in the expanding adult, autologous stem cell therapy market."

About NeoStem, Inc.NeoStem, Inc. is engaged in the development of stem cell-based therapies and building of a network of adult stem cell collection centers in the U.S. and China that are focused on enabling people to donate and store their own (autologous) stem cells for their personal use in times of future medical need.  The Company is also the licensee of various stem cell technologies, including a worldwide exclusive license to VSEL™ Technology which uses very small embryonic-like stem cells, shown to have several physical characteristics that are generally found in embryonic stem cells, and is pursuing the licensing of other technologies for therapeutic use.  NeoStem's majority-controlled Chinese pharmaceutical operation, Suzhou Erye, manufactures and distributes generic antibiotics in China.  For more information, please visit: http://www.neostem.com.

Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties.  The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2010, as well as other periodic filings made with the Securities and Exchange Commission. The Company's further development is highly dependent on future medical and research developments and market acceptance, which is outside its control.

About Maxim GroupMaxim Group LLC is a full-service investment banking firm headquartered in New York.  Maxim Group provides a full array of financial services including investment banking; private wealth management; and global institutional equity, fixed-income and derivatives sales and trading as well as equity research.  The investment banking group focuses on middle market and emerging growth companies within the shipping, energy, health care, technology, retail, and business and financial services sectors.  The institutional coverage of Maxim Group spans North and South America, Europe and Asia.  Maxim Group LLC is a registered as a broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); International Securities Exchange (ISE); NASDAQ Stock Market and the NYSE Arca, Inc.  To learn more about Maxim Group, visit www.maximgrp.com.

About The Proactive Investors One2One Investor ForumThe Proactive Investors group operates a successful "investor forums" where three or four companies present to an audience of high net sophisticated investors, fund managers, hedge funds, private client brokers and analysts.  Proactive Investors is a leading multi-media news organization, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt and London.  Proactive Investors operates five financial websites in four languages providing breaking news, comment and analysis on hundreds of listed companies across the globe daily. NeoStem, Inc.Robin Smith, CEOPhone: +1 (212) 584-4174E-mail: rsmith@neostem.comhttp://www.neostem.com
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. NeoStem Announces Pricing of Concurrent Offerings for $19 Million in Gross Proceeds
2. NeoStem Provides Third Quarter Update
3. NeoStem to Present at LifeTech Capital Miami Medical Investors Conference
4. Local Chinese Government Authorities Approve Pricing and Reimbursement for NeoStems Licensed Adult Stem Cell Treatments for Orthopedic Applications in China
5. NeoStem to Present at Cell Therapy Industry Summit to be held on November 3-5, 2010 in Carlsbad, California
6. NeoStem and Progenitor Cell Therapy Announce Entry Into Merger Agreement
7. NeoStem Comments on Recent Court Ruling Blocking the Federal Governments Funding of Embryonic Stem Cell Research
8. NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board
9. NeoStem Pharmaceutical Subsidiary Announces Two cGMP Lines are Now Fully Operational in New Facility
10. NeoStem, Inc. Officially Launches Adult Stem Cell Collection Center and R&D Laboratory in Cambridge, Massachusetts
11. NeoStem Announces Warrant Exercise by Principal Shareholder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Dec. 6, 2016 Anaplastic Oligoastrocytoma - ... Markets Direct,s latest Pharmaceutical and Healthcare disease pipeline ... provides an overview of the Anaplastic Oligoastrocytoma (Oncology) ... tumor that forms when two types of cells ... increase in number to form a mass. These ...
(Date:12/6/2016)... 2016  Nearly 30 million people in ... of diabetes. 1 However, nearly 40% of diabetes ... (hyperglycemia) and significant glucose variability. 2 These patients are ... events. If left untreated, hyperglycemia can lead to cardiovascular ... blindness. 3 As part of Diabetes ...
(Date:12/6/2016)... 2016  Arcturus Therapeutics, Inc. ("Arcturus" or the ... that it entered into collaboration with Takeda Pharmaceutical ... treatment of NASH and other gastrointestinal (GI) related ... and UNA Oligomer chemistry. The financial terms were ... to and expertise in GI disorders, we are ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... 07, 2016 , ... They are musicians and librarians, fashion designers and fitness ... from New England and around the nation. What do they have in common? All ... a beautiful and compelling new photographic exhibit debuting Friday, December 9 at Logan International ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... and financial consultation services to residents in the Sacramento/Folsom region, is initiating a ... treatment facility. , The Another Choice Another Chance treatment center in Sacramento works ...
(Date:12/7/2016)... ... ... A. Kevin Spann Insurance, a New York-based firm offering insurance and financial consultation ... drive to raise funds that will benefit the Marine Corps League. , The Marine ... Corpsmen. Working closely with the MCL, the A. Kevin Spann team plans to generate ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel ... a portion of proceeds to two local organizations: North Chicago Animal Control and Friends ... is a team of authorized and trained volunteers who support rescued animals held ...
(Date:12/7/2016)... ... 2016 , ... The medical profession is well aware that heart attacks do ... analyzing heart attacks among 138,602 people recorded a 35% higher number of heart attacks ... agree of course–no time of year is a good time for a heart attack! ...
Breaking Medicine News(10 mins):